Cardiac Surgery Department, Peking University People's Hospital, Beijing, 100044, China.
Thoracic Surgery Department, Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, China.
J Cardiothorac Surg. 2023 Apr 5;18(1):98. doi: 10.1186/s13019-023-02199-0.
Asymptomatic graft failure after coronary bypass grafting surgery (CABG) may have negative impact on the patients' short- and long-term outcomes. Cardiac computed tomography angiography (CTA) has been proved to be another choice to detect graft failure besides coronary artery angiography in several studies. We aimed to identify the rate and predictors of asymptomatic graft failure detected by CTA before discharge.
A total of 955 grafts of 346 consecutive asymptomatic patients who received CTA examination after CABGs were included in this retrospective study from July 2017 to Dec 2019. We divided 955 grafts into the patent group and occluded group by CTA results. Logistic regression model at graft-level were established to determine predictors of the early asymptomatic graft occlusion. The overall asymptomatic graft failure rate was 4.71% (45/955), and there was no difference between the arterial and venous conduits in different target territories (P > 0.05). The logistic regression at graft-level analysis showed that female (OR 3.181, CI 1.58-6.40, P = 0.001), composite grafting (OR 6.762, CI 2.26-20.28, P = 0.001), pulse index value (OR 1.180, CI 1.08-1.29, P < 0.001) and new postoperative atrial fibrillation (POAF) (OR2.348, CI 1.15-4.78, P = 0.018) were independent risk factors that affect graft failure, while early postoperative dual-antiplatelet treatment with aspirin and clopidogrel was a protective factor (OR 0.403, CI 0.19-0.84, P = 0.015).
Early asymptomatic graft failure is associated with both patient and surgical factors including female gender, high PI value, composite graft strategy and the new POAF. However, the early dual- antiplatelet therapy with aspirin and clopidogrel may be useful for preventing graft failure.
冠状动脉旁路移植术(CABG)后无症状的移植物失败可能对患者的短期和长期预后产生负面影响。心脏计算机断层血管造影(CTA)已被证明是除冠状动脉造影外检测移植物失败的另一种选择。我们旨在确定 CABG 术后通过 CTA 检测到的无症状移植物失败的发生率和预测因素。
本研究为回顾性研究,纳入 2017 年 7 月至 2019 年 12 月期间 346 例无症状接受 CTA 检查的连续患者的 955 个移植物。我们根据 CTA 结果将 955 个移植物分为通畅组和闭塞组。建立移植物水平的逻辑回归模型以确定早期无症状移植物闭塞的预测因素。总体无症状移植物失败率为 4.71%(45/955),不同靶区的动脉和静脉移植物之间无差异(P>0.05)。移植物水平的逻辑回归分析显示,女性(OR 3.181,95%CI 1.58-6.40,P=0.001)、复合移植(OR 6.762,95%CI 2.26-20.28,P=0.001)、脉搏指数值(OR 1.180,95%CI 1.08-1.29,P<0.001)和新术后心房颤动(POAF)(OR 2.348,95%CI 1.15-4.78,P=0.018)是影响移植物失败的独立危险因素,而早期术后阿司匹林和氯吡格雷双联抗血小板治疗是保护因素(OR 0.403,95%CI 0.19-0.84,P=0.015)。
早期无症状移植物失败与患者和手术因素有关,包括女性、高 PI 值、复合移植策略和新的 POAF。然而,阿司匹林和氯吡格雷双联抗血小板治疗可能有助于预防移植物失败。